Remus Pharmaceuticals Limited IPO

Remus Pharmaceuticals Limited is listed in the SME segment with a price band of ₹1,150 to ₹1,229. The figures below are as reported by the exchanges and public sources.

Remus Pharmaceuticals Limited IPO — key facts

• The Remus Pharmaceuticals Limited IPO price band is ₹1,150 to ₹1,229 per share.
• As of 5 September 2026, the Remus Pharmaceuticals Limited IPO subscription status is 57.21x overall.
• The issue is open from 17-MAY-2023 to 19-MAY-2023.
• Remus Pharmaceuticals Limited listed on 29-MAY-2023.
• Remus Pharmaceuticals Limited listed at ₹1,796.8. The listing gain was 46.2% against the upper end of the issue price band.

Remus Pharmaceuticals Limited IPO details

Status

Listed

Segment

SME

Sector

Pharmaceuticals

Price band

₹1,150 – ₹1,229

Issue size

₹45.29 Cr

Fresh issue

₹45.29 Cr

Opens

17-MAY-2023

Closes

19-MAY-2023

Listing

29-MAY-2023

Total subscription

57.21x

Retail

49.81x

QIB

10.75x

NII

229.31x

Lead managers

Beeline Capital (left lead)

Listing price

₹1,796.8

Listing day change

+46.2%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.